RATIONALE: Central airway stenosis (CAS) after lung transplantation has been attributed in part to chronic airway ischemia; however, little is known about the time course or significance of large airway hypoxia early after transplantation. OBJECTIVES: To evaluate large airway oxygenation and hypoxic gene expression during the first month after lung transplantation and their relation to airway complications. METHODS: Subjects who underwent lung transplantation underwent endobronchial tissue oximetry of native and donor bronchi at 0, 3, and 30 days after transplantation (n = 11) and/or endobronchial biopsies (n = 14) at 30 days for real-time polymerase chain reaction of hypoxia-inducible genes. Patients were monitored for 6 months for the development of transplant-related complications. MEASUREMENTS AND MAIN RESULTS: Compared with native endobronchial tissues, donor tissue oxygen saturations (Sto2) were reduced in the upper lobes (74.1 ± 1.8% vs. 68.8 ± 1.7%; P < 0.05) and lower lobes (75.6 ± 1.6% vs. 71.5 ± 1.8%; P = 0.065) at 30 days post-transplantation. Donor upper lobe and subcarina Sto2 levels were also lower than the main carina (difference of -3.9 ± 1.5 and -4.8 ± 2.1, respectively; P < 0.05) at 30 days. Up-regulation of hypoxia-inducible genes VEGFA, FLT1, VEGFC, HMOX1, and TIE2 was significant in donor airways relative to native airways (all P < 0.05). VEGFA, KDR, and HMOX1 were associated with prolonged respiratory failure, prolonged hospitalization, extensive airway necrosis, and CAS (P < 0.05). CONCLUSIONS: These findings implicate donor bronchial hypoxia as a driving factor for post-transplantation airway complications. Strategies to improve airway oxygenation, such as bronchial artery re-anastomosis and hyperbaric oxygen therapy merit clinical investigation.
RATIONALE: Central airway stenosis (CAS) after lung transplantation has been attributed in part to chronic airway ischemia; however, little is known about the time course or significance of large airway hypoxia early after transplantation. OBJECTIVES: To evaluate large airway oxygenation and hypoxic gene expression during the first month after lung transplantation and their relation to airway complications. METHODS: Subjects who underwent lung transplantation underwent endobronchial tissue oximetry of native and donor bronchi at 0, 3, and 30 days after transplantation (n = 11) and/or endobronchial biopsies (n = 14) at 30 days for real-time polymerase chain reaction of hypoxia-inducible genes. Patients were monitored for 6 months for the development of transplant-related complications. MEASUREMENTS AND MAIN RESULTS: Compared with native endobronchial tissues, donor tissue oxygen saturations (Sto2) were reduced in the upper lobes (74.1 ± 1.8% vs. 68.8 ± 1.7%; P < 0.05) and lower lobes (75.6 ± 1.6% vs. 71.5 ± 1.8%; P = 0.065) at 30 days post-transplantation. Donor upper lobe and subcarina Sto2 levels were also lower than the main carina (difference of -3.9 ± 1.5 and -4.8 ± 2.1, respectively; P < 0.05) at 30 days. Up-regulation of hypoxia-inducible genes VEGFA, FLT1, VEGFC, HMOX1, and TIE2 was significant in donor airways relative to native airways (all P < 0.05). VEGFA, KDR, and HMOX1 were associated with prolonged respiratory failure, prolonged hospitalization, extensive airway necrosis, and CAS (P < 0.05). CONCLUSIONS: These findings implicate donor bronchial hypoxia as a driving factor for post-transplantation airway complications. Strategies to improve airway oxygenation, such as bronchial artery re-anastomosis and hyperbaric oxygen therapy merit clinical investigation.
Authors: Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill Journal: J Heart Lung Transplant Date: 2005-06-04 Impact factor: 10.247
Authors: A Paul; D Marelli; H Shennib; M King; N S Wang; J A Wilson; D S Mulder; R C Chiu Journal: J Thorac Cardiovasc Surg Date: 1989-10 Impact factor: 5.209
Authors: Rainer Krebs; Jussi M Tikkanen; Antti I Nykänen; Jeanette Wood; Michael Jeltsch; Seppo Ylä-Herttuala; Petri K Koskinen; Karl B Lemström Journal: Am J Respir Crit Care Med Date: 2005-03-18 Impact factor: 21.405
Authors: Gundeep S Dhillon; Martin R Zamora; Justus E Roos; Deirdre Sheahan; Ramachandra R Sista; Pieter Van der Starre; David Weill; Mark R Nicolls Journal: Am J Respir Crit Care Med Date: 2010-03-25 Impact factor: 21.405
Authors: Mohammad A Khan; Xinguo Jiang; Gundeep Dhillon; Joshua Beilke; V Michael Holers; Carl Atkinson; Stephen Tomlinson; Mark R Nicolls Journal: Circ Res Date: 2011-10-13 Impact factor: 17.367
Authors: Heyman Luckraz; Martin Goddard; Keith McNeil; Carl Atkinson; Susan C Charman; Susan Stewart; John Wallwork Journal: J Heart Lung Transplant Date: 2004-05 Impact factor: 10.247
Authors: Anthony W Castleberry; Mathias Worni; Maragatha Kuchibhatla; Shu S Lin; Laurie D Snyder; Scott L Shofer; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig Journal: Ann Thorac Surg Date: 2013-07-18 Impact factor: 4.330
Authors: Kamran Mahmood; Bryan D Kraft; Kristen Glisinski; Matthew G Hartwig; Nicole P Harlan; Claude A Piantadosi; Scott L Shofer Journal: Clin Transplant Date: 2016-08-02 Impact factor: 2.863
Authors: Bryan D Kraft; Kamran Mahmood; Nicole P Harlan; Matthew G Hartwig; Laurie D Snyder; Hagir B Suliman; Scott L Shofer Journal: J Heart Lung Transplant Date: 2021-01-15 Impact factor: 10.247
Authors: K Mahmood; L Ebner; M He; S H Robertson; Z Wang; H P McAdams; M M Wahidi; S L Shofer; Y T Huang; B Driehuys Journal: Am J Transplant Date: 2017-05-08 Impact factor: 8.086